Dimensional Fund Advisors
VERA icon

Dimensional Fund Advisors’s Vera Therapeutics VERA Stock Holding History

Dimensional Fund Advisors’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22.7M Buy
527,853
+249,088
+89% +$9.28M ﹤0.01% 1986
2026
Q1 		$11.2M Sell
278,765
-73,121
-21% -$3.15M ﹤0.01% 2218
2025
Q4 		$17.8M Sell
351,886
-8,446
-2% -$300K ﹤0.01% 2028
2025
Q3 		$10.5M Buy
360,332
+206,652
+134% +$4.78M ﹤0.01% 2287
2025
Q2 		$3.62M Buy
153,680
+139,912
+1,016% +$3.15M ﹤0.01% 2610
2025
Q1 		$331K Sell
13,768
-2,064
-13% -$66.3K ﹤0.01% 3058
2024
Q4 		$670K Sell
15,832
-1,900
-11% -$84.1K ﹤0.01% 2991
2024
Q3 		$784K Hold
17,732
– – ﹤0.01% 2950
2024
Q2 		$642K Hold
17,732
– – ﹤0.01% 2987
2024
Q1 		$765K Sell
17,732
-33,190
-65% -$1.18M ﹤0.01% 2963
2023
Q4 		$783K Buy
+50,922
New +$647K ﹤0.01% 2975

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dimensional Fund Advisors's VERA Position: Q2 2026 in Review

Dimensional Fund Advisors increased its Vera Therapeutics (VERA) stake by 89% in Q2 2026, buying an estimated $9.28M and bringing the position to 527,853 shares worth $22.7M. The position accounts for ﹤0.01% of the portfolio, ranked #1986.

Dimensional Fund Advisors first reported a position in VERA in Q4 2023 and has held it in 11 quarters since. 219 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • Dimensional Fund Advisors held 527,853 shares of Vera Therapeutics worth $22.7M as of Q2 2026.
  • Dimensional Fund Advisors bought 249,088 Vera Therapeutics shares in Q2 2026, an estimated $9.28M.
  • Vera Therapeutics made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q2 2026, its #1986 holding.
  • Dimensional Fund Advisors first reported a position in Vera Therapeutics in Q4 2023 and has held it in 11 quarters since.
  • 219 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.